Updated On: 16 June, 2024 03:39 PM IST | Mumbai | IANS
According to MIT, rather than drawing blood, this device uses light to look through the skin at the top of the fingernail and artificial intelligence to analyse and detect when WBCs reach dangerously low levels

Image for representational purposes only. Photo Courtesy: iStock
US-based firm Leuko, founded by a research team at the Massachusetts Institute of Technology (MIT), has developed a device that will give doctors a non-invasive way to monitor cancer patients` health during chemotherapy -- without the need of blood tests.